Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Für diesen Artikel ist leider kein Bild verfügbar.

Evaluation of Chemotherapy in Bladder Cancer

Buch | Hardcover
264 Seiten
1993
Churchill Livingstone (Verlag)
978-0-443-04644-5 (ISBN)
CHF 104,75 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
One of the five reports based on papers and discussions held at key sessions of the Societe International d'Urologie's 22nd congress, this book aims to provide state-of-the-art coverage of chemotherapy for bladder cancer and should enable the practising urologist to keep up to date in this area.
In November 1991 the Societe International d'Urologie (SIU) held it 22nd congress in Seville and five reports, based on papers and discussions at key sessions, will be published at intervals, in Autumn 1992. "Evaluation of Chemotherapy for Bladder Cancer" aims to provide state-of-the-art coverage of this topic, with contributions from international specialists. This book should enable the practising urologist to keep completely up to date in this fast-moving area of urology, with important new developments covered, and in-depth analysis of current trends. Other titles in the series include: "Non-Surgical Treatment of BPH"; "Continent Urinary Diversion"; "Oncogenes and Molecular Genetics of Urological Tumours"; and "Urinary Incontinence".

The evaluation of prophylactic intravescial chemotherapy for superficial bladder cancer; treatment of TIS of the urinary bladder - first results of protocol of the EORTC protocol 30861; interferon alfa-AB 60 million vs 100 millions in intravesical prophylaxis of superficial bladder cancer; long-term follow-up of camptothecin instillation for prevention and treatment of urinary bladder tumors; the fate of G3 pTI bladder cancer - progression, recurrence and survival; whole layer needle biopsy to evaluate neoadjuvant therapy in invasive bladder cancer; laparoscopic lymphadenectomy - a new option for staging in bladder cancer; radical TUR and chemotherapy aiming at bladder preservation; BHCG and bladder cancer; the Cueto prospective study 84005 on neoadjuvant cisplatinum before radical cystectomy - survival at 3.5 years; progress report on the overview of two randomized trials of cisplatinum in invasive transitional cell carcinoma of the bladder; preliminary analysis of a random study of neoadjuvant chemotherapy plus cystectomy versus cystectomy in patients with invasive bladder carcinoma; EORTC studies on first-line chemotherapy in invasive bladder cancer; chemotherapy for advanced bladder cancer - three kinds of regimes (MVAC, CAP and CAF); role of chemo-Rx-therapy; neoadjuvant chemo and radiotherapy versus radiotherapy as precystectomy treatment in bladder cancer; is pelvis lymphadenectomy curative for N1 bladder tumors?; histological interpretation of the post chemotherapy urinary bladder cancer; chemotherapy in metastatic disease.

Erscheint lt. Verlag 1.2.1993
Reihe/Serie International Society of Urology Reports S.
Zusatzinfo 20 line drawings, 35 half-tones
Verlagsort London
Sprache englisch
Maße 293 x 29 mm
Gewicht 672 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Medizinische Fachgebiete Urologie
Studium Querschnittsbereiche Infektiologie / Immunologie
ISBN-10 0-443-04644-1 / 0443046441
ISBN-13 978-0-443-04644-5 / 9780443046445
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Oliver Schmetzer

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 37,80